540 related articles for article (PubMed ID: 19026265)
1. Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.
Saavedra-Velez C; Yusim A; Anbarasan D; Lindenmayer JP
J Clin Psychiatry; 2009 Jan; 70(1):104-12. PubMed ID: 19026265
[TBL] [Abstract][Full Text] [Related]
2. Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial.
Freudenreich O; Henderson DC; Macklin EA; Evins AE; Fan X; Cather C; Walsh JP; Goff DC
J Clin Psychiatry; 2009 Dec; 70(12):1674-80. PubMed ID: 19689921
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications.
Sevy S; Rosenthal MH; Alvir J; Meyer S; Visweswaraiah H; Gunduz-Bruce H; Schooler NR
J Clin Psychiatry; 2005 Jul; 66(7):839-43. PubMed ID: 16013898
[TBL] [Abstract][Full Text] [Related]
4. Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
Kane JM; D'Souza DC; Patkar AA; Youakim JM; Tiller JM; Yang R; Keefe RS
J Clin Psychiatry; 2010 Nov; 71(11):1475-81. PubMed ID: 20816042
[TBL] [Abstract][Full Text] [Related]
5. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.
DeBattista C; Doghramji K; Menza MA; Rosenthal MH; Fieve RR;
J Clin Psychiatry; 2003 Sep; 64(9):1057-64. PubMed ID: 14628981
[TBL] [Abstract][Full Text] [Related]
6. Effects of modafinil on cognitive functions in first episode psychosis.
Scoriels L; Barnett JH; Soma PK; Sahakian BJ; Jones PB
Psychopharmacology (Berl); 2012 Mar; 220(2):249-58. PubMed ID: 21909634
[TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia.
Arbabi M; Bagheri M; Rezaei F; Ahmadi-Abhari SA; Tabrizi M; Khalighi-Sigaroudi F; Akhondzadeh S
Psychopharmacology (Berl); 2012 Apr; 220(3):591-8. PubMed ID: 21947320
[TBL] [Abstract][Full Text] [Related]
8. Intractability of Deficit Syndrome of Schizophrenia Against Adjunctive Modafinil.
Shoja Shafti S; Akbari S
J Clin Psychopharmacol; 2016 Feb; 36(1):45-9. PubMed ID: 26658259
[TBL] [Abstract][Full Text] [Related]
9. Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study.
Lohr JB; Liu L; Caligiuri MP; Kash TP; May TA; Murphy JD; Ancoli-Israel S
Schizophr Res; 2013 Oct; 150(1):289-96. PubMed ID: 23938173
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia.
Pierre JM; Peloian JH; Wirshing DA; Wirshing WC; Marder SR
J Clin Psychiatry; 2007 May; 68(5):705-10. PubMed ID: 17503979
[TBL] [Abstract][Full Text] [Related]
11. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants.
Lam JY; Freeman MK; Cates ME
Ann Pharmacother; 2007 Jun; 41(6):1005-12. PubMed ID: 17519297
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: systematic review and meta-analysis of randomized controlled trials.
Andrade C; Kisely S; Monteiro I; Rao S
J Psychiatr Res; 2015 Jan; 60():14-21. PubMed ID: 25306261
[TBL] [Abstract][Full Text] [Related]
13. Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia.
Rosenthal MH; Bryant SL
Clin Neuropharmacol; 2004; 27(1):38-43. PubMed ID: 15090936
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of modafinil: Potential clinical uses and mechanisms of action.
Ballon JS; Feifel D
J Clin Psychiatry; 2006 Apr; 67(4):554-66. PubMed ID: 16669720
[TBL] [Abstract][Full Text] [Related]
16. The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial.
Bobo WV; Woodward ND; Sim MY; Jayathilake K; Meltzer HY
Schizophr Res; 2011 Aug; 130(1-3):106-13. PubMed ID: 21641776
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of modafinil in the treatment of cancer-related fatigue.
Cooper MR; Bird HM; Steinberg M
Ann Pharmacother; 2009 Apr; 43(4):721-5. PubMed ID: 19318599
[TBL] [Abstract][Full Text] [Related]
18. Impact of modafinil on prefrontal executive function in schizophrenia.
Hunter MD; Ganesan V; Wilkinson ID; Spence SA
Am J Psychiatry; 2006 Dec; 163(12):2184-6. PubMed ID: 17151173
[TBL] [Abstract][Full Text] [Related]
19. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study.
Rossi A; Mancini F; Stratta P; Mattei P; Gismondi R; Pozzi F; Casacchia M
Acta Psychiatr Scand; 1997 Jan; 95(1):40-3. PubMed ID: 9051159
[TBL] [Abstract][Full Text] [Related]
20. Modafinil in schizophrenia: is the risk worth taking?
Neto D; Spínola C; Gago J
BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28583922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
